Clinical Report: Dana-Farber/Boston Children's Named Top Pediatric Cancer Program

Overview

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center has been recognized as the #1 pediatric cancer program in the nation for 2026-2027 by U.S. News & World Report.

Background

The recognition of pediatric cancer programs reflects the quality of care provided to children with cancer and blood disorders. The rankings are based on various factors, including clinical outcomes and compliance with best practices.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

• Dana-Farber/Boston Children’s has been ranked among the top three pediatric cancer centers since 2007.
• It has received more #1 rankings than any other program in the nation.
• The program emphasizes expert, personalized cancer care for children and young adults.
• U.S. News & World Report's rankings are based on clinical outcomes and hospital resources.
• Recognition highlights the commitment to transformative research and training future pediatric hematology/oncology providers.

Clinical Implications

The ranking reflects the program's performance in pediatric oncology.

Conclusion

Dana-Farber/Boston Children’s has been recognized as the top pediatric cancer program.

Related Resources & Content

1. U.S. News & World Report, 2026-2027 -- Dana-Farber/Boston Children's Named Top Pediatric Cancer Program
2. dana-farber — Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants
3. The ASCO Post — U.S. News & World Report Announces 2026–2027 Best Cancer Hospitals
4. The ASCO Post — U.S. News & World Report Announces 2026–2027 Best Cancer Hospitals
5. U.S. News & World Report Announces 2026–2027 Best Cancer Hospitals
6. Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed
7. Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children | New England Journal of Medicine
8. Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®) - NCI